Yada, K.
378  results:
Search for persons X
?
2

Emicizumab, the bispecific antibody to factorsIX/IXa and X/..:

Minami, H. ; Nogami, K. ; Yada, K....
Journal of Thrombosis and Haemostasis.  17 (2018)  1 - p. 126-137 , 2018
 
?
8

Assessing the clinical severity of type 1 von Willebrand di..:

Nogami, K. ; Ogiwara, K. ; Yada, K....
Journal of Thrombosis and Haemostasis.  14 (2016)  4 - p. 667-674 , 2016
 
?
9

Systematic monitoring of hemostatic management in hemophili..:

Furukawa, S. ; Nogami, K. ; Ogiwara, K....
Journal of Thrombosis and Haemostasis.  13 (2015)  7 - p. 1279-1284 , 2015
 
?
10

Mild hemophilia A patient with novel Pro1809Leu mutation de..:

Yada, K. ; Nogami, K. ; Takeyama, M....
Journal of Thrombosis and Haemostasis.  13 (2015)  10 - p. 1843-1853 , 2015
 
?
14

Activated prothrombin complex concentrate (APCC)-mediated a..:

Yada, K. ; Nogami, K. ; Ogiwara, K..
Journal of Thrombosis and Haemostasis.  11 (2013)  5 - p. 902-910 , 2013
 
?
15

Investigation of detached recombining deuterium plasma and ..:

Yada, K. ; Matsui, N. ; Ohno, N....
Journal of Nuclear Materials.  390-391 (2009)  - p. 290-294 , 2009
 
1-15